• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非霍奇金淋巴瘤

Non-Hodgkin's lymphomas.

作者信息

Haller D G

出版信息

Med Clin North Am. 1984 May;68(3):741-56. doi: 10.1016/s0025-7125(16)31126-9.

DOI:10.1016/s0025-7125(16)31126-9
PMID:6205233
Abstract

The non-Hodgkin's lymphomas, although sharing a common origin, often present physicians with wide variations in natural history and prognosis. The proper therapy of these diseases is based on an understanding of these differences and upon the information gained by pathologic review and staging, as well as the available chemotherapeutic and radiotherapeutic options.

摘要

非霍奇金淋巴瘤虽然起源相同,但常常使医生面临其自然病程和预后差异很大的情况。这些疾病的恰当治疗基于对这些差异的理解,以及病理检查和分期所获得的信息,还有现有的化疗和放疗选择。

相似文献

1
Non-Hodgkin's lymphomas.非霍奇金淋巴瘤
Med Clin North Am. 1984 May;68(3):741-56. doi: 10.1016/s0025-7125(16)31126-9.
2
Management of the indolent non-Hodgkin's lymphomas.
Semin Oncol. 1980 Sep;7(3):292-301.
3
A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851.甲氨蝶呤剂量及博来霉素加入CHOP方案治疗弥漫性大细胞淋巴瘤和其他非霍奇金淋巴瘤的随机对照研究。癌症与白血病B组研究7851。
Cancer. 1990 Nov 1;66(9):1888-96. doi: 10.1002/1097-0142(19901101)66:9<1888::aid-cncr2820660906>3.0.co;2-k.
4
Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
N Engl J Med. 2005 Mar 24;352(12):1250-2. doi: 10.1056/NEJMe048345.
5
Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
J Chemother. 1989 Jul;1(4 Suppl):1259-62.
6
Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.晚期弥漫性非霍奇金淋巴瘤。在一项多组研究中通过国际预后指数和乳酸脱氢酶分析预后因素。
Cancer. 1995 Feb 1;75(3):865-73. doi: 10.1002/1097-0142(19950201)75:3<865::aid-cncr2820750319>3.0.co;2-z.
7
[Treatment of non-Hodgkin malignant lymphomas].[非霍奇金恶性淋巴瘤的治疗]
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1984 Jan-Feb;36(1):1-10.
8
Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group.在III-IV期中级和高级非霍奇金淋巴瘤患者中,在环磷酰胺/羟基柔红霉素/VM-26/泼尼松联合方案(CHVmP)基础上加用长春新碱和博来霉素后疗效持续改善。欧洲癌症研究与治疗组织淋巴瘤协作组。
Ann Oncol. 1997;8 Suppl 1:67-70.
9
Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas.IV期非霍奇金淋巴瘤中的非交叉耐药组合。
Cancer Treat Rep. 1977 Sep;61(6):1117-23.
10
Advances in adult non-Hodgkin's lymphoma. Current concepts of classification, diagnosis, and management.
Arch Intern Med. 1980 Dec;140(12):1647-51.